Search NLS News

New research shows that ILB mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including Amyothrophic Lateral Sclerosis (ALS). TikoMed has announced the publication in Frontiers in Phamacology of peer-reviewed research supporting the broad spectrum mechanism of action of TikoMed’s ILB neuroprotective drug platform. In […]

The two companies have entered into an agreement under which Novo Nordisk will acquire Forma Therapeutics for 20 USD per share in cash, which represents a total equity value of 1.1 billion USD. Forma Therapeutics is a clinical-stage biopharmaceutical company focused on transforming the lives of patients with sickle cell disease (SCD) and rare blood […]

EpiEndo Pharmaceuticals has received regulatory and ethics approval to commence a Lipopolysaccharide (LPS) challenge clinical trial with its lead molecule EP395. EP395 is an orally available macrolide or ‘Barriolide’ with reduced antimicrobial activity which aims to address the unmet medical need for a treatment for COPD (Chronic Obstructive Pulmonary Disease). “Commencing this study is the […]

The rector of the University of Helsinki has appointed Professor Jari Koistinaho as director of the Helsinki Institute of Life Science (HiLIFE). “The life science disciplines are developing globally in leaps and bounds, thanks to new knowledge and the latest technologies,” notes Koistinaho. “Breakthroughs in life science will change our view of ourselves as humans […]

ScandiDos has completed a directed share issue to IBA Dosimetry of 4,150,000 shares at a subscription price of 3 SEK per share, whereby the company receives approximately 12,45 million SEK before transaction costs. The strategic alliance that is being created between ScandiDos and IBA in quality assurance for radiation therapy enables a collaboration between the […]

Nordic Biomarker has been awarded as the Export Success of the Year in Sweden 2022. The prize was awarded August 31, by Minister of Foreign Trade Anna Hallberg in the presence of H.K.H. Prince Daniel. The first Alumni of Umeå Biotech Incubator Nordic Biomarker develops, manufactures and sells reagents for coagulation diagnostics. The company, who […]

Earlier this summer Immunicum announced a corporate rebranding and name change to Mendus and most recently the company reported financing commitments totaling up to 250 million SEK. NLS asked Erik Manting, CEO, about what lies ahead. What opportunities do you have on the market for cancer immunotherapy? “Many cancer patients today experience an initial treatment […]

Last year Kaiku Health announced its collaboration with Novartis in developing digital patient monitoring and management for melanoma patients. Following the success of the collaboration, Kaiku Health and Novartis are now expanding it into a partnership, they state. “The cooperation so far has shown that together we can enhance the monitoring and symptom management of […]

The FDA has accepted for priority review the Biologics License Application for efanesoctocog alfa for the treatment of hemophilia A. Sanofi and Sobi collaborate on the development and commercialization of efanesoctocog alfa. “Factor therapy remains a cornerstone of hemophilia treatment, but innovation has been needed in this area to address challenges related to bleed protection […]

Sara Mangsbo, Senior Lecturer at the Department of Pharmacy and Chief Innovation Officer at Ultimovacs, receives the BiotechBuilders Award 2022. The award is given each year to an entrepreneur who has created unique opportunities which brings the Swedish life science industry forward. The organization behind the award, BiotechBuilders, states in its motivation that Sara Mangsbo […]